Our Mission

The Epilepsy Study Consortium (TESC) is a group of scientific investigators from academic medical research centers who are dedicated to accelerating the development of new therapies in epilepsy to improve patient care. The organization’s goals include building a partnership between academics, industry and regulatory agencies and optimizing clinical trial methodology in order to responsibly speed new treatments to patients.

Read more about who we are

Since 2007 the epilepsy study consortium has assisted with the design and conduct of more than 100 clinical trials. As a result our experience, tools, and network can help accomplish faster and safer epilepsy trials.

Who, What, How?

What is the Epilepsy Consortium?
How do you advance epilepsy research?
Do you Create innovative trial designs?
Who does the Epilepsy Consortium Collaborate with?

Read more on our About Us page

ETDD Symposium

ETDD Symposium

For over 25 years, researchers from academic epilepsy, governmental agencies such as the Food and Drug Administration, the National Institutes of Health, and pharmaceutical and device industry researchers have been meeting on a biennial basis to discuss ways to expedite new epilepsy therapies to patients.

Read more at ETDDtrials.com